Question 1

What factors should I consider when comparing Canara Robeco Equity Hybrid Fund - Direct (G) vs Nippon India Pharma Fund - Direct (G)?

Accepted Answer

When comparing Canara Robeco Equity Hybrid Fund - Direct (G) vs Nippon India Pharma Fund - Direct (G), consider factors such as historical performance, expense ratios, investment strategy, risk level, and the fund manager's credibility. Moreover, look at asset allocation and how each fund fits your investment goals.

Question 2

Can I invest in Canara Robeco Equity Hybrid Fund - Direct (G) and Nippon India Pharma Fund - Direct (G) simultaneously?

Accepted Answer

Yes, you can invest in both Canara Robeco Equity Hybrid Fund - Direct (G) and Nippon India Pharma Fund - Direct (G) at the same time. This can help diversify your portfolio and balance risk, provided the fund manager's investment strategies streamline each other.

Question 3

What does the portfolio turnover ratio tell us when comparing Canara Robeco Equity Hybrid Fund - Direct (G) and Nippon India Pharma Fund - Direct (G)?

Accepted Answer

While comparing Canara Robeco Equity Hybrid Fund - Direct (G) and Nippon India Pharma Fund - Direct (G), the portfolio turnover ratio indicates how frequently assets within the fund are bought and sold. A high turnover may lead to higher transaction costs and tax implications, while a low turnover ratio indicates a buy-and-hold strategy.

Question 4

Can I switch between Canara Robeco Equity Hybrid Fund - Direct (G) and Nippon India Pharma Fund - Direct (G) if needed?

Accepted Answer

Yes, you can typically switch between Canara Robeco Equity Hybrid Fund - Direct (G) and Nippon India Pharma Fund - Direct (G), subject to the fund's policies and any applicable fees. It is important to consider potential tax implications and the timing of your switch.

Question 5

Can I compare Canara Robeco Equity Hybrid Fund - Direct (G) and Nippon India Pharma Fund - Direct (G) based on their dividend payout?

Accepted Answer

Yes, you can compare Canara Robeco Equity Hybrid Fund - Direct (G) and Nippon India Pharma Fund - Direct (G) based on their dividend payouts. Look at dividends profit, consistency, and growth, as these factors can influence your overall return on investment.

Canara Robeco Equity Hybrid Fund - Direct (G) vs Nippon India Pharma Fund - Direct (G)

Canara Robeco Equity Hybrid Fund - Direct (G)

2.99%

Nippon India Pharma Fund - Direct (G)

7.4%

About Fund

Fund Details

Get your FAQs right